http://www.pharmaceutical-technology.com/news/fabre-kramer-depressive-disorder-therapy/
Fabre-Kramer has obtained approval from the US FDA for Exxua to treat major depressive disorder (MDD) in adult patients.
Create an account or login to join the discussion